InvestorsHub Logo
Followers 21
Posts 12423
Boards Moderated 3
Alias Born 07/06/2003

Re: pennstreet post# 38242

Tuesday, 08/14/2012 10:43:01 AM

Tuesday, August 14, 2012 10:43:01 AM

Post# of 45771
Assuming for moment that your version is true...Then we are left with the latest version imagined up for VALIMED..A failed product from the past..dependent upon Wade for expertise in further development..

And the MYTH GUN in various versions...for which MP, WADE, and RYLES own the patent.

Then the bunch of LUBBOCK that want the entire company pledged to them in exchange for a small loan..and the other creditors not get anything. Except a remote and extremely unlikely result that the modified VALIMED...admittedly not yet completed, will sell very well indeed. Run up the SP, and allow the unsecured creditors to reap at least some part of their money by selling their shares..

Whereas, the impaired and unsecured creditors are assured that they will get nothing unless they vote to allow the LUBBOCKERS to make this small loan because that will force CHAP 7 on CDEX. CDEX cannot survive w/o money. BLACKMAIL!!

The KEY being WADE now outted as consorting with the "enemy", MP and RYLES. Further, WADE taking only a cursory interest in the activities in the LAB and working only part-time.

GOOD OLE WADE the one knowing better than anyone the technical aspects of the VALIMED ..Unless WADE can make it fly..nobody can.
A New "scientist" would require a LONG LEARNING CURVE far beyond the lasting power of the small loan from the LUBBOCKERS. And handicapped by a likely hard opinion that the VALIMED is an unreliable waste of time and money..and not enough of either.
"IF IT IS ANY GOOD, HOWCOME IT HAS NEVER SOLD WELL???".

IN THE MEANTIME...the present shareholders like the rest of the world..can only watch and wait. they have no vote.


Ole Crowe

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.